MDA-MB-231 breast cancer cells were transduced with individual MCL1-degrader fusions, and endogenous MCL1 protein levels were assessed by Western blot 72 hrs post-transduction (Fig. S6). This evidence concerns the gene MCL1 and breast carcinoma.